Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 15-Feb-24 4:21 PM View:  | Larimar Therapeutics, Inc. (LRMR) | 14-Feb-24 | Purchase | 2,000 | $11.00 | $22,000.00 | 100% 0 to 2.0K | |
| 24-Jan-24 5:27 PM View: | Orchard Therapeutics Plc (ORTX) | 24-Jan-24 | Disposition | 92,081 | -- | -- | (100%) 92.08K to 0 | |
| 10-Oct-23 5:39 PM View: | Spero Therapeutics, Inc. (SPRO) | 05-Oct-23 | Grant | 20,000 | -- | -- | 133% 15.0K to 35.0K | |
| 14-Mar-23 8:30 AM View: | Orchard Therapeutics Plc (ORTX) | 10-Mar-23 | Option Exercise | 20,000 | $0.46 | $9,182.00 | 28% 72.08K to 92.08K | |
| 13-Feb-23 8:09 AM View: | Orchard Therapeutics Plc (ORTX) | 09-Feb-23 | Option Exercise | 20,000 | $0.46 | $9,182.00 | 38% 52.08K to 72.08K | |
| 19-Sep-22 5:40 PM View: | Spero Therapeutics, Inc. (SPRO) | 15-Sep-22 | Grant | 15,000 | -- | -- | 100% 0 to 15.0K | |
| 04-Apr-22 4:15 PM View: | Orchard Therapeutics Plc (ORTX) | 01-Apr-22 | Private Purchase | 10,000 | $0.75 | $7,474.00 | 24% 42.08K to 52.08K | |
| 01-Feb-21 4:15 PM View: | Orchard Therapeutics Plc (ORTX) | 29-Jan-21 | Option Exercise | 10,000 | $2.44 | $24,400.00 | 31% 32.08K to 42.08K | |
| 12-Jan-21 4:49 PM View: | Orchard Therapeutics Plc (ORTX) | 11-Jan-21 | Payment of Exercise | 3,706 | $6.72 | $24,904.30 | (10%) 35.79K to 32.08K | |
| 12-Jan-21 4:49 PM View: | Orchard Therapeutics Plc (ORTX) | 08-Jan-21 | Grant | 10,667 | -- | -- | 42% 25.12K to 35.79K | |
| 15-Jun-20 5:03 PM View: | Orchard Therapeutics Plc (ORTX) | 11-Jun-20 | Option Exercise | 10,000 | $2.44 | $24,400.00 | 66% 15.12K to 25.12K | |
| 27-Feb-17 7:01 PM View: | AMAG Pharmaceuticals, Inc. (AMAG) | 23-Feb-17 | Grant | 24,000 | -- | -- | 21% 114.19K to 138.19K | |
| 01-Mar-16 5:33 PM View: | AMAG Pharmaceuticals, Inc. (AMAG) | 01-Mar-16 | Grant | 17,000 | -- | -- | 17% 97.19K to 114.19K | |
| 01-Mar-16 5:33 PM View: | AMAG Pharmaceuticals, Inc. (AMAG) | 29-Feb-16 | Payment of Exercise | 515 | $26.28 | $13,534.20 | (< 1%) 97.71K to 97.19K | 36% |
| 01-Mar-16 5:33 PM View: | AMAG Pharmaceuticals, Inc. (AMAG) | 27-Feb-16 | Payment of Exercise | 458 | $27.01 | $12,370.60 | (< 1%) 98.17K to 97.71K | 38% |
| 01-Mar-16 5:33 PM View: | AMAG Pharmaceuticals, Inc. (AMAG) | 26-Feb-16 | Payment of Exercise | 8,778 | $27.01 | $237,094.00 | (8%) 106.95K to 98.17K | 38% |
| 21-Aug-15 4:05 PM View: | AMAG Pharmaceuticals, Inc. (AMAG) | 20-Aug-15 | Payment of Exercise | 2,363 | $61.71 | $145,821.00 | (2%) 109.31K to 106.95K | 73% |
| 07-Aug-15 5:24 PM View: | AMAG Pharmaceuticals, Inc. (AMAG) | 05-Aug-15 | Option Exercise | 15,000 | $14.91 | $223,650.00 | 14% 109.31K to 124.31K | |
| 07-Aug-15 5:24 PM View: | AMAG Pharmaceuticals, Inc. (AMAG) | 05-Aug-15 | Market Option Sale (Planned) | 15,000 | $66.85 | $1,002,750.00 | (12%) 124.31K to 109.31K | 75% |
| 08-Jun-15 4:35 PM View: | AMAG Pharmaceuticals, Inc. (AMAG) | 04-Jun-15 | Market Sale | 20,000 | $69.47 | $1,389,320.00 | (15%) 129.31K to 109.31K | 76% |
| 05-Mar-15 5:10 PM View: | AMAG Pharmaceuticals, Inc. (AMAG) | 03-Mar-15 | Payment of Exercise | 4,279 | $49.70 | $212,666.00 | (3%) 133.59K to 129.31K | 66% |
| 27-Feb-15 4:54 PM View: | AMAG Pharmaceuticals, Inc. (AMAG) | 26-Feb-15 | Grant | 12,500 | -- | -- | 10% 121.09K to 133.59K | |
| 18-Dec-14 5:16 PM View: | AMAG Pharmaceuticals, Inc. (AMAG) | 17-Dec-14 | Payment of Exercise | 7,046 | $40.49 | $285,293.00 | (5%) 128.13K to 121.09K | 59% |
| 21-Aug-14 4:19 PM View: | AMAG Pharmaceuticals, Inc. (AMAG) | 19-Aug-14 | Grant | 40,000 | -- | -- | 45% 88.13K to 128.13K | |
| 28-Feb-14 5:40 PM View: | AMAG Pharmaceuticals, Inc. (AMAG) | 27-Feb-14 | Grant | 5,600 | -- | -- | 7% 82.53K to 88.13K | |
| 17-Dec-13 4:38 PM View: | AMAG Pharmaceuticals, Inc. (AMAG) | 16-Dec-13 | Payment of Exercise | 3,266 | $23.23 | $75,869.20 | (4%) 85.8K to 82.53K | 28% |
| 04-Mar-13 4:35 PM View: | AMAG Pharmaceuticals, Inc. (AMAG) | 28-Feb-13 | Grant | 18,800 | -- | -- | 85% 22.0K to 40.8K | |
| 04-Jan-13 4:34 PM View: | AMAG Pharmaceuticals, Inc. (AMAG) | 03-Jan-13 | Option Exercise | 20,000 | -- | -- | 167% 12.0K to 32.0K | |
| 04-Jan-13 4:34 PM View: | AMAG Pharmaceuticals, Inc. (AMAG) | 03-Jan-13 | Market Option Sale (Planned) | 10,000 | $15.60 | $155,969.00 | (31%) 32.0K to 22.0K | (7%) |
| 04-Dec-12 7:26 AM View: | AMAG Pharmaceuticals, Inc. (AMAG) | 30-Nov-12 | Option Exercise | 10,000 | -- | -- | 143% 7.0K to 17.0K | |
| 04-Dec-12 7:26 AM View: | AMAG Pharmaceuticals, Inc. (AMAG) | 30-Nov-12 | Market Option Sale (Planned) | 5,000 | $15.08 | $75,400.00 | (29%) 17.0K to 12.0K | (11%) |
| 03-Aug-12 8:57 AM View: | AMAG Pharmaceuticals, Inc. (AMAG) | 01-Aug-12 | Conversion | 5,000 | -- | -- | 100% 0 to 5.0K | |
| 02-Apr-12 4:00 PM View: | AMAG Pharmaceuticals, Inc. (AMAG) | 02-Apr-12 | Market Purchase (Planned) | 500 | $15.86 | $7,930.00 | 33% 1.5K to 2.0K | 5% |
| 02-Mar-12 4:21 PM View: | AMAG Pharmaceuticals, Inc. (AMAG) | 01-Mar-12 | Market Purchase (Planned) | 500 | $15.81 | $7,905.00 | 50% 1.0K to 1.5K | 6% |
| 02-Feb-12 9:35 AM View: | AMAG Pharmaceuticals, Inc. (AMAG) | 01-Feb-12 | Market Purchase (Planned) | 500 | $16.56 | $8,280.00 | 100% 0.5K to 1.0K | < 1% |
| 04-Jan-12 4:00 PM View: | AMAG Pharmaceuticals, Inc. (AMAG) | 03-Jan-12 | Market Purchase (Planned) | 500 | $19.10 | $9,550.00 | 100% 0 to 0.5K | (13%) |
| 22-Aug-07 10:00 PM View: | Critical Therapeutics Inc. (CRTX) | 22-Aug-07 | Market Purchase | 5,000 | $2.12 | $10,620.00 | 7% 67.03K to 72.03K | (82%) |
| 14-Jun-07 8:58 AM View: | Critical Therapeutics Inc. (CRTX) | 13-Jun-07 | Grant | 1,500 | $2.24 | $3,360.00 | 2% 65.53K to 67.03K | (83%) |
| 07-Jun-07 8:50 AM View: | Critical Therapeutics Inc. (CRTX) | 06-Jun-07 | Grant | 1,500 | $2.69 | $4,035.00 | 2% 64.03K to 65.53K | (86%) |
| 05-Jun-07 1:23 PM View: | Critical Therapeutics Inc. (CRTX) | 04-Jun-07 | Grant | 2,000 | $2.75 | $5,500.00 | 3% 62.03K to 64.03K | (86%) |
| 04-Jun-07 9:40 AM View: | Critical Therapeutics Inc. (CRTX) | 31-May-07 | Acquisition (other) | 2,148 | $1.59 | $3,415.32 | 4% 59.88K to 62.03K | |
| 29-Dec-06 12:07 PM View: | Critical Therapeutics Inc. (CRTX) | 27-Dec-06 | Grant | 40,000 | $40.00 | $1,600,000.00 | 201% 19.89K to 59.88K | |
| 04-Dec-06 5:13 PM View: | Critical Therapeutics Inc. (CRTX) | 30-Nov-06 | Acquisition (other) | 1,885 | $1.66 | $3,129.10 | 10% 18.0K to 19.89K | |
| 10-Aug-06 8:41 AM View: | Critical Therapeutics Inc. (CRTX) | 08-Aug-06 | Grant | 4,000 | $3.90 | $15,600.00 | 29% 14.0K to 18.0K | (90%) |
| 02-Nov-05 4:24 PM View: | Critical Therapeutics Inc. (CRTX) | 02-Nov-05 | Option Exercise | 1,000 | $5.63 | $5,630.00 | 8% 13.0K to 14.0K | |
| 15-Sep-05 1:54 PM View: | Critical Therapeutics Inc. (CRTX) | 14-Sep-05 | Option Exercise | 1,000 | $5.63 | $5,630.00 | 8% 12.0K to 13.0K | |
| 25-Jan-05 3:49 PM View: | Critical Therapeutics Inc. (CRTX) | 25-Jan-05 | Option Exercise | 2,000 | $5.63 | $11,260.00 | 2% 118.0K to 120.0K | |
| 09-Feb-04 10:00 PM View: | Esperion Therapeutics Inc/mi (ESPR) | 05-Feb-04 | Option Exercise | 46,799 | -- | -- | 2365% 1.98K to 48.78K | |
| 09-Feb-04 10:00 PM View: | Esperion Therapeutics Inc/mi (ESPR) | 05-Feb-04 | Disposition (change in control) | 48,778 | $35.00 | $1,707,230.00 | (100%) 48.78K to 0 | |
| 02-Jan-04 10:00 PM View: | Esperion Therapeutics Inc/mi (ESPR) | 30-Dec-03 | Option Exercise | 1,000 | $5.00 | $5,000.00 | 105% 0.95K to 1.95K |